Literature DB >> 6135927

Melphalan adjuvant therapy in breast cancer.

J T Carpenter, W A Maddox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6135927     DOI： 10.1016/s0140-6736(83)90407-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  In vitro selective effect of melphalan on human T-cell populations.

Authors:  S Ben-Efraim; L Komlos; J Notmann; J Hart; I Halbrecht
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

2.  Use of the comet assay technique for quick and reliable prediction of in vitro response to chemotherapeutics in breast and colon cancer.

Authors:  Panagiotis Apostolou; Maria Toloudi; Eleni Kourtidou; Georgia Mimikakou; Ioanna Vlachou; Marina Chatziioannou; Ioannis Papasotiriou
Journal:  J Biol Res (Thessalon)       Date:  2014-08-01       Impact factor: 1.889
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.